Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Puregossipon Sep 03, 2022 11:15am
257 Views
Post# 34939998

RE:RE:Stalled.

RE:RE:Stalled.
RDF was a binding contract and yes we saw the numbers and how did that go?

This SBM team has proven to stand beside the big companies and that is for sure. But , really. The only thing that can be judged is when profits are made and not salaries,.

Stop suggesting otherwise. 

I will suggest biorun, if the  RDF contact is seen once more  or it mimics the RDF result. I am sure holders of SBM will turn fore the worse, Till such a deal is shared  with fact and not just words  and stuck at 18-21 are speed bumps  and not hills

Stop suggesting otherwise

As for your 170 post, based on all the results to date by SBM seems odd, given most of your post defends your words or how blue the sky will be with SBM.

I do expect a rebut biorun that will make you at 171 sorry you will not get a 3rd from me, till results happen and I can applaud mangement for its several years of work.



 


<< Previous
Bullboard Posts
Next >>